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Items for this week’s EPI Update include: 
Influenza identified in Iowa 
Rhinovirus outbreak: Lab reporting essential 
Emerging diseases vs. those commonly found in Iowa 
Stroke death rates continue to decline in Iowa 
Azithromycin often prescribed incorrectly for children 
In the news: Probiotic bacteria could protect newborns  
Infographic: The impact of unsafe medical injections in the U.S. 
Meeting announcements and training opportunities 
 
Influenza identified in Iowa 
Iowa’s influenza surveillance network has already identified a handful of influenza 
cases this fall. Please encourage almost everyone over 6 months of age to get 
the flu vaccine, especially those at increased risk of severe complications.  
 
It has been a severe flu season in the southern hemisphere in places like 
Australia and New Zealand, which may indicate that Iowa is in for a severe flu 
season this winter. 
 
For more information about influenza, visit www.idph.iowa.gov/influenza.  
 
Rhinovirus outbreak: Lab reporting essential 
A respiratory illness outbreak in a nursing home was investigated this week. 
Residents and staff were experiencing moderately severe symptoms that 
included fever, sore throat and cough. Laboratory testing at SHL determined that 
rhinovirus was the cause and allowed for specific guidance needed to control this 
outbreak (i.e., antivirals are not recommended as they do not work against 
rhinovirus, but good environmental cleaning, limiting visitors and isolation of ill 
patients was recommended.) 
 
All outbreaks are reportable to IDPH, and in the case of respiratory illness 
outbreaks, public health can help in determining the specific cause with 
laboratory testing and offer appropriate guidelines for treatment and prevention.  
 
For more information about respiratory/influenza outbreaks in long-term care 
facilities, visit idph.iowa.gov/influenza/ltc-facilities.  
 
Emerging diseases vs. those commonly found in Iowa 
This week, a recent traveler to the Middle East and a non-travelling family 
member became ill with severe respiratory illnesses and were hospitalized.  
Consideration of diseases not found in Iowa like MERS (Middle East Respiratory 
Syndrome) is important in travelers (and others they may have exposed).  
 
Hospitals and clinics are often the first line of defense against emerging 
diseases, so it is always important to screen patients for travel history; however, 
most ill travelers do not become ill with exotic emerging diseases, but with more 
common diseases. These two people were laboratory confirmed to have 
influenza.   
 
For more information about emerging infectious diseases, visit 
www.cdc.gov/ncezid/index.html.  
 
Stroke death rates continue to decline in Iowa 
In a recent EPI Update, a CDC Vital Signs report was highlighted which 
described how progress in preventing stroke deaths has stalled in a majority of 
states. Fortunately, Iowa was one of 13 states where stroke death rates have 
continued to decrease in adults 35 years and older. In 2015, Iowa ranked 11th 
nationally for stroke mortality. The Iowa stroke rate reduced by 33 percent 
between 2005 and 2015. Since 2012, the Iowa stroke death rate has decreased 
enough to meet the national Healthy People 2020 objective of 34.8 per 100,000. 
 
This continued progress can be partially attributed to: 
• education on stroke prevention information (knowing signs and symptoms 
and immediately calling 911),  
• strengthening of stroke triage and care at the Primary Stroke Centers 
throughout the state,  
• changing EMS protocols to include immediate transfer of stroke patients to 
the closest and highest level of stroke center, and  
• developing and implementing the Iowa Stroke Registry. 
 
For more information about the Iowa Stroke Registry, visit 
idph.iowa.gov/Portals/1/userfiles/78/ISR%20Stroke%20Factsheet%209-
17%20%282%29.pdf. 
 
Azithromycin often prescribed incorrectly for children 
A recent CDC study found that azithromycin is likely misused in many cases, 
especially for children. When antibiotics were prescribed, family practitioners 
were more likely to choose azithromycin than were pediatricians. (Amoxicillin, a 
recommended first-line antibiotic for common illnesses in children, was the most 
commonly prescribed antibiotic, followed by azithromycin.)  
 
This is concerning because azithromycin is not a recommended treatment for 
common pediatric infections and the misuse of azithromycin leads to antibiotic 
resistance. In 2013, children were prescribed 66.8 million antibiotics – 35 percent 
of prescriptions were for amoxicillin and 18 percent were for azithromycin. 
 
CDC’s Core Elements of Outpatient Antibiotic Stewardship can help prescribers 
improve antibiotic selection and reduce overuse of antibiotics in children. To view 
the framework, visit www.cdc.gov/getsmart/community/improving-
prescribing/core-elements/core-outpatient-stewardship.html.  
 
In the news: Probiotic bacteria could protect newborns 
www.npr.org/sections/goatsandsoda/2017/08/16/543920822/probiotic-bacteria-
could-protect-newborns-from-deadly-infection  
 
Infographic: The impact of unsafe medical injections in the US 
www.oneandonlycampaign.org/sites/default/files/upload/pdf/SIPC_infographic.pd
f  
 
Meeting announcements and training opportunities 
None 
 
Have a healthy and happy week! 
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